Published in Ann Oncol on October 27, 2006
American Society of Clinical Oncology Clinical Practice Guideline update on chemotherapy for stage IV non-small-cell lung cancer. J Clin Oncol (2009) 4.95
Docetaxel weekly regimen in conjunction with RF hyperthermia for pretreated locally advanced non-small cell lung cancer: a preliminary study. BMC Cancer (2007) 0.99
Personalized medicine for targeted and platinum-based chemotherapy of lung and bladder cancer. Bioanalysis (2013) 0.88
The impact of chemotherapy-induced side effects on medical care usage and cost in German hospital care--an observational analysis on non-small-cell lung cancer patients. Support Care Cancer (2013) 0.88
C-Jun N-terminal kinase signalling pathway in response to cisplatin. J Cell Mol Med (2016) 0.77
Lung cancer. BMJ Clin Evid (2009) 0.75
Refining the treatment of advanced nonsmall cell lung cancer. Lung Cancer (Auckl) (2010) 0.75
Lung cancer. BMJ Clin Evid (2010) 0.75
Treatment of metastatic malignant melanoma with dacarbazine plus tamoxifen. N Engl J Med (1992) 3.11
Charcot-Marie-Tooth type 4B is caused by mutations in the gene encoding myotubularin-related protein-2. Nat Genet (2000) 2.96
Temporal lobe abnormalities on brain MRI in healthy volunteers: a prospective case-control study. Neurology (2010) 2.27
Intracranial hypertension in head injury: management and results. Intensive Care Med (1999) 2.21
Prospective randomized trial of docetaxel versus doxorubicin in patients with metastatic breast cancer. J Clin Oncol (1999) 2.19
Identification of the gene for oral-facial-digital type I syndrome. Am J Hum Genet (2001) 2.07
Intrinsic epileptogenicity of human dysplastic cortex as suggested by corticography and surgical results. Ann Neurol (1995) 2.00
Periventricular heterotopia: phenotypic heterogeneity and correlation with Filamin A mutations. Brain (2006) 2.00
The nicotinic receptor beta 2 subunit is mutant in nocturnal frontal lobe epilepsy. Nat Genet (2000) 1.73
Comparison and reproducibility of visual echocardiographic and quantitative radionuclide left ventricular ejection fractions. Am J Cardiol (1996) 1.69
Daily magnesium supplements improve glucose handling in elderly subjects. Am J Clin Nutr (1992) 1.65
Prevention of sore throat after nasotracheal intubation. J Oral Maxillofac Surg (1988) 1.61
In vivo tumor targeting of a recombinant single-chain antigen-binding protein. J Natl Cancer Inst (1990) 1.61
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
Gemcitabine plus vinorelbine versus vinorelbine alone in elderly patients with advanced non-small-cell lung cancer. J Clin Oncol (2000) 1.59
Prognostic importance of insulin-mediated glucose uptake in aged patients with congestive heart failure secondary to mitral and/or aortic valve disease. Am J Cardiol (1999) 1.56
The parkin gene is not involved in late-onset Parkinson's disease. Neurology (2001) 1.51
Switching to anastrozole versus continued tamoxifen treatment of early breast cancer. Updated results of the Italian tamoxifen anastrozole (ITA) trial. Ann Oncol (2006) 1.47
The long-duration response to L-dopa in the treatment of early PD. Neurology (2000) 1.46
Effects of insulin on the cardiac autonomic nervous system in insulin-resistant states. Clin Sci (Lond) (2000) 1.45
Phase II study of intensive CEV (carboplatin, epirubicin and VP-16) plus G-CSF (granulocyte-colony stimulating factor) in extensive small cell lung cancer. Eur J Cancer (1995) 1.42
Coal fly ash as raw material for the manufacture of geopolymer-based products. Waste Manag (2007) 1.42
Opposite effects of short- and long-term fatty acid infusion on insulin secretion in healthy subjects. Diabetologia (1995) 1.42
Cerebral venous thrombosis and isolated intracranial hypertension without papilledema in CDH. Neurology (2001) 1.42
Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41
Investigator-initiated trials of targeted oncology agents: why independent research is at risk? Ann Oncol (2010) 1.41
Incidence in Italy, genetic heterogeneity, and segregation analysis of cystic fibrosis. Am J Hum Genet (1985) 1.41
In vivo fate of monoclonal antibody B72.3 in patients with colorectal cancer. J Nucl Med (1990) 1.41
Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7 TeV. Phys Rev Lett (2011) 1.39
Antiemetic activity of high-dose metoclopramide combined with methylprednisolone versus metoclopramide alone in dacarbazine-treated cancer patients. A randomized double-blind study of the Italian Oncology Group for Clinical Research. Am J Clin Oncol (1989) 1.38
Attention-deficit hyperactivity disorder: sometimes a disorder, often a clinical tautology. J Dev Behav Pediatr (1996) 1.38
Determination of the strange-quark density of the proton from ATLAS measurements of the W→ℓν and Z→ℓℓ cross sections. Phys Rev Lett (2012) 1.34
Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32
Observation of associated near-side and away-side long-range correlations in sqrt[s(NN)]=5.02 TeV proton-lead collisions with the ATLAS detector. Phys Rev Lett (2013) 1.27
A randomized controlled trial assessing the prevention of doxorubicin cardiomyopathy by N-acetylcysteine. Semin Oncol (1983) 1.27
Novel SACS mutations in autosomal recessive spastic ataxia of Charlevoix-Saguenay type. Neurology (2004) 1.26
Tamoxifen alone versus adjuvant tamoxifen for operable breast cancer of the elderly: long-term results of the phase III randomized controlled multicenter GRETA trial. Ann Oncol (2003) 1.25
Patterns of antimicrobial use and antimicrobial resistance among healthy children in Bolivia. Trop Med Int Health (1998) 1.24
Epilepsy, cysticercosis, and toxocariasis: a population-based case-control study in rural Bolivia. Neurology (2002) 1.24
Human placental neuraminidase. Activation, stabilization and association with beta-galactosidase and its protective protein. Eur J Biochem (1985) 1.23
Prevalence of epilepsy in rural Bolivia: a door-to-door survey. Neurology (1999) 1.21
Search for dark matter candidates and large extra dimensions in events with a photon and missing transverse momentum in pp collision data at sqrt[s]=7 TeV with the ATLAS detector. Phys Rev Lett (2013) 1.19
Total-body and myocardial substrate oxidation in congestive heart failure. Metabolism (1994) 1.19
Gemcitabine with or without continuous infusion 5-FU in advanced pancreatic cancer: a randomised phase II trial of the Italian oncology group for clinical research (GOIRC). Br J Cancer (2005) 1.18
Presenilin-1-associated abnormalities in regional cerebral perfusion. Neurology (2001) 1.17
Characterization and biodistribution of recombinant and recombinant/chimeric constructs of monoclonal antibody B72.3. Cancer Res (1989) 1.16
Advancing age and insulin resistance: role of plasma tumor necrosis factor-alpha. Am J Physiol (1998) 1.15
Search for a supersymmetric partner to the top quark in final states with jets and missing transverse momentum at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.13
Glucose tolerance and insulin action in healty centenarians. Am J Physiol (1996) 1.13
Localization of a gene responsible for autosomal recessive demyelinating neuropathy with focally folded myelin sheaths to chromosome 11q23 by homozygosity mapping and haplotype sharing. Hum Mol Genet (1996) 1.13
Radioimmunolocalization of human carcinoma xenografts with B72.3 second generation monoclonal antibodies. Cancer Res (1988) 1.12
Alteration of the in vivo nicotinic receptor density in ADNFLE patients: a PET study. Brain (2006) 1.11
The use of external fixators in femur fractures in children. J Pediatr Orthop (1997) 1.07
Search for tb resonances in proton-proton collisions at √s=7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.07
Autosomal recessive hereditary motor and sensory neuropathy with focally folded myelin sheaths: clinical, electrophysiologic, and genetic aspects of a large family. Neurology (1996) 1.07
PAX6 mutation in a family with aniridia, congenital ptosis, and mental retardation. Clin Genet (2001) 1.07
Treatment and recycling of asbestos-cement containing waste. J Hazard Mater (2011) 1.07
Randomised trial comparing biweekly oxaliplatin plus oral capecitabine versus oxaliplatin plus i.v. bolus fluorouracil/leucovorin in metastatic colorectal cancer patients: results of the Southern Italy Cooperative Oncology study 0401. J Cancer Res Clin Oncol (2008) 1.06
Soluble salt removal from MSWI fly ash and its stabilization for safer disposal and recovery as road basement material. Waste Manag (2012) 1.05
Dopamine D2 receptor gene polymorphism and the risk of levodopa-induced dyskinesias in PD. Neurology (1999) 1.05
CA 72-4 serum marker--a new tool in the management of carcinoma patients. Cancer Invest (1995) 1.05
Search for a light Higgs boson decaying to long-lived weakly interacting particles in proton-proton collisions at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.05
Phase II, open-label study of PTK787/ZK222584 for the treatment of metastatic gastrointestinal stromal tumors resistant to imatinib mesylate. Ann Oncol (2007) 1.04
Hippocampal and thalamic atrophy in mild temporal lobe epilepsy: a VBM study. Neurology (2008) 1.04
Serum levels of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 in healthy centenarians: relationship with plasma leptin and lipid concentrations, insulin action, and cognitive function. J Clin Endocrinol Metab (1997) 1.03
Does free fatty acid infusion impair insulin action also through an increase in oxidative stress? J Clin Endocrinol Metab (1996) 1.02
Plasma leptin concentrations and cardiac autonomic nervous system in healthy subjects with different body weights. J Clin Endocrinol Metab (2000) 1.02
Gemcitabine plus vinorelbine yields better survival outcome than vinorelbine alone in elderly patients with advanced non-small cell lung cancer. A Southern Italy Cooperative Oncology Group (SICOG) phase III trial. Lung Cancer (2001) 1.02
MRI evidence of mesial temporal sclerosis in sporadic "benign" temporal lobe epilepsy. Neurology (2006) 1.02
Effect of training on H(2)O(2) release by mitochondria from rat skeletal muscle. Arch Biochem Biophys (1999) 1.01
Characterization of the sialidase molecular defects in sialidosis patients suggests the structural organization of the lysosomal multienzyme complex. Hum Mol Genet (2000) 1.01
Phase III randomized study of fluorouracil, epirubicin, and cyclophosphamide v fluorouracil, doxorubicin, and cyclophosphamide in advanced breast cancer: an Italian multicentre trial. J Clin Oncol (1988) 1.01
Nuclear changes in a case of X-linked Emery-Dreifuss muscular dystrophy. Muscle Nerve (1999) 1.00
Phase II study of continuous-infusion high-dose ifosfamide in advanced and/or metastatic pretreated soft tissue sarcomas. Ann Oncol (1997) 0.99
Search for supersymmetry in events with three leptons and missing transverse momentum in √[s]=7 TeV pp collisions with the ATLAS detector. Phys Rev Lett (2012) 0.99
Mansonella ozzardi infection in Bolivia: prevalence and clinical associations in the Chaco region. Am J Trop Med Hyg (1999) 0.99
Loss of long-duration response to levodopa over time in PD: implications for wearing-off. Neurology (1999) 0.99
Effect of metformin on food intake in obese subjects. Eur J Clin Invest (1998) 0.99
Lowering fatty acids potentiates acute insulin response in first degree relatives of people with type II diabetes. Diabetologia (1998) 0.98
Association of fasting plasma free fatty acid concentration and frequency of ventricular premature complexes in nonischemic non-insulin-dependent diabetic patients. Am J Cardiol (1997) 0.98